KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addus HomeCare (ADUS) Gains from Investment Securities (2016 - 2025)

Addus HomeCare (ADUS) has disclosed Gains from Investment Securities for 16 consecutive years, with -$11000.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Gains from Investment Securities fell 184.62% year-over-year to -$11000.0, compared with a TTM value of $19.4 million through Mar 2025, up 29.18%, and an annual FY2024 reading of $406000.0, down 97.29% over the prior year.
  • Gains from Investment Securities was -$11000.0 for Q1 2025 at Addus HomeCare, down from $406000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $14.0 million in Q2 2024 and bottomed at -$39000.0 in Q1 2023.
  • Average Gains from Investment Securities over 5 years is $3.5 million, with a median of $3.4 million recorded in 2021.
  • The sharpest move saw Gains from Investment Securities surged 417.56% in 2023, then plummeted 184.62% in 2025.
  • Year by year, Gains from Investment Securities stood at $3.1 million in 2021, then tumbled by 72.03% to $854000.0 in 2022, then soared by 417.56% to $4.4 million in 2023, then tumbled by 90.81% to $406000.0 in 2024, then plummeted by 102.71% to -$11000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for ADUS at -$11000.0 in Q1 2025, $406000.0 in Q4 2024, and $5.4 million in Q3 2024.